Using the miraEST Assembler for Reliable and Automated mRNA Transcript Assembly and SNP Detection in Sequenced ESTs (original) (raw)

  1. Bastien Chevreux1,7,
  2. Thomas Pfisterer2,
  3. Bernd Drescher3,
  4. Albert J. Driesel4,
  5. Werner E.G. Müller5,
  6. Thomas Wetter6, and
  7. Sándor Suhai1
  8. 1 Department of Molecular Biophysics, German Cancer Research Centre Heidelberg, 69120 Heidelberg, Germany
  9. 2 MWG Biotech AG, 85560 Ebersberg, Germany
  10. 3 RZPD German Resource Center for Genome Research, 14059 Berlin, Germany
  11. 4 VitiGen AG, 76833 Siebeldingen, Germany
  12. 5 Abteilung Angewandte Molekularbiologie, Institut für Physiologische Chemie, Universität Mainz, 55099 Mainz, Germany
  13. 6 Institute for Medical Biometry and Informatics, University of Heidelberg, 69120 Heidelberg, Germany

Abstract

We present an EST sequence assembler that specializes in reconstruction of pristine mRNA transcripts, while at the same time detecting and classifying single nucleotide polymorphisms (SNPs) occuring in different variations thereof. The assembler uses iterative multipass strategies centered on high-confidence regions within sequences and has a fallback strategy for using low-confidence regions when needed. It features special functions to assemble high numbers of highly similar sequences without prior masking, an automatic editor that edits and analyzes alignments by inspecting the underlying traces, and detection and classification of sequence properties like SNPs with a high specificity and a sensitivity down to one mutation per sequence. In addition, it includes possibilities to use incorrectly preprocessed sequences, routines to make use of additional sequencing information such as base-error probabilities, template insert sizes, strain information, etc., and functions to detect and resolve possible misassemblies. The assembler is routinely used for such various tasks as mutation detection in different cell types, similarity analysis of transcripts between organisms, and pristine assembly of sequences from various sources for oligo design in clinical microarray experiments.

Footnotes